Prudential Financial
PNT

Prudential Financial’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Prudential Financial’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-65,840
Closed -$439K – 2744
2023
Q3 		$439K Buy
65,840
+3,644
+6% +$30.3K ﹤0.01% 2112
2023
Q2 		$563K Buy
+62,196
New +$549K ﹤0.01% 2064

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Prudential Financial's PNT Position: Q4 2023 in Review

Prudential Financial sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 65,840 shares — an estimated $439K sold.

Prudential Financial first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $563K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Prudential Financial reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prudential Financial sold 65,840 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $439K.
  • Prudential Financial first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Prudential Financial's POINT Biopharma Global Inc. Common Stock position peaked at $563K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Prudential Financial's 13F filing for Q4 2023, filed 13 Feb 2024.